Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex

Growing evidence indicates that there is an interaction between the transmission of dopamine (DA) and norepinephrine (NE) in the noradrenergic and dopaminergic projections that converge in the medial prefrontal cortex (mPFC). The effects of the noradrenergic α1 and α2 receptors and the NE transporte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Synapse (New York, N.Y.) N.Y.), 2004-07, Vol.53 (1), p.44-52
Hauptverfasser: Pan, Wynn H.T., Yang, Sze-Yuan, Lin, Shi-Kwang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 52
container_issue 1
container_start_page 44
container_title Synapse (New York, N.Y.)
container_volume 53
creator Pan, Wynn H.T.
Yang, Sze-Yuan
Lin, Shi-Kwang
description Growing evidence indicates that there is an interaction between the transmission of dopamine (DA) and norepinephrine (NE) in the noradrenergic and dopaminergic projections that converge in the medial prefrontal cortex (mPFC). The effects of the noradrenergic α1 and α2 receptors and the NE transporters on the DA outflow and those of the dopaminergic D1 and D2 receptors on NE release in the mPFC were investigated. Local infusions of NE (90, 150, and 300 nM) into the mPFC increased the extracellular release of DA in anesthetized rats. The α1 receptor antagonist (10 μM prazosin), but not the α2 receptor antagonist (100 μM piperoxan), blocked the NE‐induced increase of DA in the mPFC. In addition, local infusion of α1 receptor agonist (10 μM phenylephrine) enhanced DA release in the mPFC. Local application of DA in different concentrations into the mPFC increased extracellular NE levels. Intra‐mPFC infusion of a D1 receptor antagonist (10 nM SCH23390), inhibited the DA‐induced increase of NE; this did not happen with a D2 receptor antagonist (1 nM eticlopride). Local administration of a selective NE uptake inhibitor (1 μM desmethylimipramine) into the mPFC increased the outflows of both DA and NE in the mPFC. However, co‐infusion of DMI and prazosin blunted, but did not totally abolish, the DMI‐increase in the extracellular levels of DA and NE. These results suggest that in the mPFC, 1) extracellular NE could enhance DA release by activating the α1 receptors; and 2) extracellular DA increased the extracellular levels of NE by activating the D1 receptors. Synapse 53:44–52, 2004. © 2004 Wiley‐Liss, Inc.
doi_str_mv 10.1002/syn.20034
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71951557</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71951557</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4504-3870b8636c053403a13a42bb06d17eb4f0aac661579c5220b3268beb508b4a0e3</originalsourceid><addsrcrecordid>eNp1kE1PGzEQhq0KVALl0D-A9oTUw8J4_bV7rFAbkGg40Ao4WbZ30pjueoO9UZp_X0NSOHHyaPS8jzwvIZ8pnFGA6jxtwlkFwPgHMqHQ1GXFGrlHJlDXquRcyQNymNIjZIQC_0gOqKACFIcJWcxwFQe3wN470xU-jBiNG_0QCovjGjEU7bA0vQ8Yf3tXmNAWYYimjbjbhGdBSDlajAssemx9Fi0jzvN6zKMb4oh_P5H9uekSHu_eI_Lr-7efF5fl9c306uLrdem4AF6yWoGtJZMOBOPADGWGV9aCbKlCy-dgjJOSCtU4UVVgWSVri1ZAbbkBZEfkdOtdxuFphWnUvU8Ou84EHFZJK9rk44XK4Jct6OKQUv6uXkbfm7jRFPRzrTrXql9qzezJTrqy-cA3ctdjBs63wNp3uHnfpG8fZv-V5TbhU27nNWHiHy0VU0Lfzaa6YT-m04bfa2D_AI9Ekf0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71951557</pqid></control><display><type>article</type><title>Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Pan, Wynn H.T. ; Yang, Sze-Yuan ; Lin, Shi-Kwang</creator><creatorcontrib>Pan, Wynn H.T. ; Yang, Sze-Yuan ; Lin, Shi-Kwang</creatorcontrib><description>Growing evidence indicates that there is an interaction between the transmission of dopamine (DA) and norepinephrine (NE) in the noradrenergic and dopaminergic projections that converge in the medial prefrontal cortex (mPFC). The effects of the noradrenergic α1 and α2 receptors and the NE transporters on the DA outflow and those of the dopaminergic D1 and D2 receptors on NE release in the mPFC were investigated. Local infusions of NE (90, 150, and 300 nM) into the mPFC increased the extracellular release of DA in anesthetized rats. The α1 receptor antagonist (10 μM prazosin), but not the α2 receptor antagonist (100 μM piperoxan), blocked the NE‐induced increase of DA in the mPFC. In addition, local infusion of α1 receptor agonist (10 μM phenylephrine) enhanced DA release in the mPFC. Local application of DA in different concentrations into the mPFC increased extracellular NE levels. Intra‐mPFC infusion of a D1 receptor antagonist (10 nM SCH23390), inhibited the DA‐induced increase of NE; this did not happen with a D2 receptor antagonist (1 nM eticlopride). Local administration of a selective NE uptake inhibitor (1 μM desmethylimipramine) into the mPFC increased the outflows of both DA and NE in the mPFC. However, co‐infusion of DMI and prazosin blunted, but did not totally abolish, the DMI‐increase in the extracellular levels of DA and NE. These results suggest that in the mPFC, 1) extracellular NE could enhance DA release by activating the α1 receptors; and 2) extracellular DA increased the extracellular levels of NE by activating the D1 receptors. Synapse 53:44–52, 2004. © 2004 Wiley‐Liss, Inc.</description><identifier>ISSN: 0887-4476</identifier><identifier>EISSN: 1098-2396</identifier><identifier>DOI: 10.1002/syn.20034</identifier><identifier>PMID: 15150740</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adrenergic alpha-Agonists - administration &amp; dosage ; Adrenergic alpha-Antagonists - administration &amp; dosage ; Animals ; catecholamine ; Dopamine - administration &amp; dosage ; Dopamine - metabolism ; Dopamine Antagonists - administration &amp; dosage ; frontal cortex ; Injections, Intraventricular ; Male ; Microdialysis ; Neurons - drug effects ; Neurons - metabolism ; neurotransmission ; Norepinephrine - administration &amp; dosage ; Norepinephrine - metabolism ; Prefrontal Cortex - drug effects ; Prefrontal Cortex - metabolism ; Rats ; Rats, Sprague-Dawley ; Receptors, Adrenergic, alpha-1 - metabolism ; Receptors, Adrenergic, alpha-2 - metabolism ; Receptors, Dopamine D1 - metabolism ; Receptors, Dopamine D2 - metabolism</subject><ispartof>Synapse (New York, N.Y.), 2004-07, Vol.53 (1), p.44-52</ispartof><rights>Copyright © 2004 Wiley‐Liss, Inc.</rights><rights>Copyright 2004 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4504-3870b8636c053403a13a42bb06d17eb4f0aac661579c5220b3268beb508b4a0e3</citedby><cites>FETCH-LOGICAL-c4504-3870b8636c053403a13a42bb06d17eb4f0aac661579c5220b3268beb508b4a0e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fsyn.20034$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fsyn.20034$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15150740$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pan, Wynn H.T.</creatorcontrib><creatorcontrib>Yang, Sze-Yuan</creatorcontrib><creatorcontrib>Lin, Shi-Kwang</creatorcontrib><title>Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex</title><title>Synapse (New York, N.Y.)</title><addtitle>Synapse</addtitle><description>Growing evidence indicates that there is an interaction between the transmission of dopamine (DA) and norepinephrine (NE) in the noradrenergic and dopaminergic projections that converge in the medial prefrontal cortex (mPFC). The effects of the noradrenergic α1 and α2 receptors and the NE transporters on the DA outflow and those of the dopaminergic D1 and D2 receptors on NE release in the mPFC were investigated. Local infusions of NE (90, 150, and 300 nM) into the mPFC increased the extracellular release of DA in anesthetized rats. The α1 receptor antagonist (10 μM prazosin), but not the α2 receptor antagonist (100 μM piperoxan), blocked the NE‐induced increase of DA in the mPFC. In addition, local infusion of α1 receptor agonist (10 μM phenylephrine) enhanced DA release in the mPFC. Local application of DA in different concentrations into the mPFC increased extracellular NE levels. Intra‐mPFC infusion of a D1 receptor antagonist (10 nM SCH23390), inhibited the DA‐induced increase of NE; this did not happen with a D2 receptor antagonist (1 nM eticlopride). Local administration of a selective NE uptake inhibitor (1 μM desmethylimipramine) into the mPFC increased the outflows of both DA and NE in the mPFC. However, co‐infusion of DMI and prazosin blunted, but did not totally abolish, the DMI‐increase in the extracellular levels of DA and NE. These results suggest that in the mPFC, 1) extracellular NE could enhance DA release by activating the α1 receptors; and 2) extracellular DA increased the extracellular levels of NE by activating the D1 receptors. Synapse 53:44–52, 2004. © 2004 Wiley‐Liss, Inc.</description><subject>Adrenergic alpha-Agonists - administration &amp; dosage</subject><subject>Adrenergic alpha-Antagonists - administration &amp; dosage</subject><subject>Animals</subject><subject>catecholamine</subject><subject>Dopamine - administration &amp; dosage</subject><subject>Dopamine - metabolism</subject><subject>Dopamine Antagonists - administration &amp; dosage</subject><subject>frontal cortex</subject><subject>Injections, Intraventricular</subject><subject>Male</subject><subject>Microdialysis</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>neurotransmission</subject><subject>Norepinephrine - administration &amp; dosage</subject><subject>Norepinephrine - metabolism</subject><subject>Prefrontal Cortex - drug effects</subject><subject>Prefrontal Cortex - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Adrenergic, alpha-1 - metabolism</subject><subject>Receptors, Adrenergic, alpha-2 - metabolism</subject><subject>Receptors, Dopamine D1 - metabolism</subject><subject>Receptors, Dopamine D2 - metabolism</subject><issn>0887-4476</issn><issn>1098-2396</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1PGzEQhq0KVALl0D-A9oTUw8J4_bV7rFAbkGg40Ao4WbZ30pjueoO9UZp_X0NSOHHyaPS8jzwvIZ8pnFGA6jxtwlkFwPgHMqHQ1GXFGrlHJlDXquRcyQNymNIjZIQC_0gOqKACFIcJWcxwFQe3wN470xU-jBiNG_0QCovjGjEU7bA0vQ8Yf3tXmNAWYYimjbjbhGdBSDlajAssemx9Fi0jzvN6zKMb4oh_P5H9uekSHu_eI_Lr-7efF5fl9c306uLrdem4AF6yWoGtJZMOBOPADGWGV9aCbKlCy-dgjJOSCtU4UVVgWSVri1ZAbbkBZEfkdOtdxuFphWnUvU8Ou84EHFZJK9rk44XK4Jct6OKQUv6uXkbfm7jRFPRzrTrXql9qzezJTrqy-cA3ctdjBs63wNp3uHnfpG8fZv-V5TbhU27nNWHiHy0VU0Lfzaa6YT-m04bfa2D_AI9Ekf0</recordid><startdate>200407</startdate><enddate>200407</enddate><creator>Pan, Wynn H.T.</creator><creator>Yang, Sze-Yuan</creator><creator>Lin, Shi-Kwang</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200407</creationdate><title>Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex</title><author>Pan, Wynn H.T. ; Yang, Sze-Yuan ; Lin, Shi-Kwang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4504-3870b8636c053403a13a42bb06d17eb4f0aac661579c5220b3268beb508b4a0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adrenergic alpha-Agonists - administration &amp; dosage</topic><topic>Adrenergic alpha-Antagonists - administration &amp; dosage</topic><topic>Animals</topic><topic>catecholamine</topic><topic>Dopamine - administration &amp; dosage</topic><topic>Dopamine - metabolism</topic><topic>Dopamine Antagonists - administration &amp; dosage</topic><topic>frontal cortex</topic><topic>Injections, Intraventricular</topic><topic>Male</topic><topic>Microdialysis</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>neurotransmission</topic><topic>Norepinephrine - administration &amp; dosage</topic><topic>Norepinephrine - metabolism</topic><topic>Prefrontal Cortex - drug effects</topic><topic>Prefrontal Cortex - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Adrenergic, alpha-1 - metabolism</topic><topic>Receptors, Adrenergic, alpha-2 - metabolism</topic><topic>Receptors, Dopamine D1 - metabolism</topic><topic>Receptors, Dopamine D2 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pan, Wynn H.T.</creatorcontrib><creatorcontrib>Yang, Sze-Yuan</creatorcontrib><creatorcontrib>Lin, Shi-Kwang</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Synapse (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Wynn H.T.</au><au>Yang, Sze-Yuan</au><au>Lin, Shi-Kwang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex</atitle><jtitle>Synapse (New York, N.Y.)</jtitle><addtitle>Synapse</addtitle><date>2004-07</date><risdate>2004</risdate><volume>53</volume><issue>1</issue><spage>44</spage><epage>52</epage><pages>44-52</pages><issn>0887-4476</issn><eissn>1098-2396</eissn><abstract>Growing evidence indicates that there is an interaction between the transmission of dopamine (DA) and norepinephrine (NE) in the noradrenergic and dopaminergic projections that converge in the medial prefrontal cortex (mPFC). The effects of the noradrenergic α1 and α2 receptors and the NE transporters on the DA outflow and those of the dopaminergic D1 and D2 receptors on NE release in the mPFC were investigated. Local infusions of NE (90, 150, and 300 nM) into the mPFC increased the extracellular release of DA in anesthetized rats. The α1 receptor antagonist (10 μM prazosin), but not the α2 receptor antagonist (100 μM piperoxan), blocked the NE‐induced increase of DA in the mPFC. In addition, local infusion of α1 receptor agonist (10 μM phenylephrine) enhanced DA release in the mPFC. Local application of DA in different concentrations into the mPFC increased extracellular NE levels. Intra‐mPFC infusion of a D1 receptor antagonist (10 nM SCH23390), inhibited the DA‐induced increase of NE; this did not happen with a D2 receptor antagonist (1 nM eticlopride). Local administration of a selective NE uptake inhibitor (1 μM desmethylimipramine) into the mPFC increased the outflows of both DA and NE in the mPFC. However, co‐infusion of DMI and prazosin blunted, but did not totally abolish, the DMI‐increase in the extracellular levels of DA and NE. These results suggest that in the mPFC, 1) extracellular NE could enhance DA release by activating the α1 receptors; and 2) extracellular DA increased the extracellular levels of NE by activating the D1 receptors. Synapse 53:44–52, 2004. © 2004 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15150740</pmid><doi>10.1002/syn.20034</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0887-4476
ispartof Synapse (New York, N.Y.), 2004-07, Vol.53 (1), p.44-52
issn 0887-4476
1098-2396
language eng
recordid cdi_proquest_miscellaneous_71951557
source MEDLINE; Wiley Online Library All Journals
subjects Adrenergic alpha-Agonists - administration & dosage
Adrenergic alpha-Antagonists - administration & dosage
Animals
catecholamine
Dopamine - administration & dosage
Dopamine - metabolism
Dopamine Antagonists - administration & dosage
frontal cortex
Injections, Intraventricular
Male
Microdialysis
Neurons - drug effects
Neurons - metabolism
neurotransmission
Norepinephrine - administration & dosage
Norepinephrine - metabolism
Prefrontal Cortex - drug effects
Prefrontal Cortex - metabolism
Rats
Rats, Sprague-Dawley
Receptors, Adrenergic, alpha-1 - metabolism
Receptors, Adrenergic, alpha-2 - metabolism
Receptors, Dopamine D1 - metabolism
Receptors, Dopamine D2 - metabolism
title Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T02%3A51%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurochemical%20interaction%20between%20dopaminergic%20and%20noradrenergic%20neurons%20in%20the%20medial%20prefrontal%20cortex&rft.jtitle=Synapse%20(New%20York,%20N.Y.)&rft.au=Pan,%20Wynn%20H.T.&rft.date=2004-07&rft.volume=53&rft.issue=1&rft.spage=44&rft.epage=52&rft.pages=44-52&rft.issn=0887-4476&rft.eissn=1098-2396&rft_id=info:doi/10.1002/syn.20034&rft_dat=%3Cproquest_cross%3E71951557%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71951557&rft_id=info:pmid/15150740&rfr_iscdi=true